Ella Liberzon

1.3k total citations · 1 hit paper
9 papers, 529 citations indexed

About

Ella Liberzon is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ella Liberzon has authored 9 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Ella Liberzon's work include Sarcoma Diagnosis and Treatment (3 papers), DNA Repair Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ella Liberzon is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), DNA Repair Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ella Liberzon collaborates with scholars based in Israel and United States. Ella Liberzon's co-authors include William G. Kaelin, Hyejin Cho, Abhishek A. Chakraborty, Ingrid Carvo, Xinlin Du, Eli M. Wallace, James P. Rizzi, Sabina Signoretti, Richard K. Bruick and John A. Josey and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Cancer.

In The Last Decade

Ella Liberzon

9 papers receiving 518 citations

Hit Papers

On-target efficacy of a HIF-2α antagonist in preclinical ... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ella Liberzon Israel 8 313 278 177 111 45 9 529
Juehui Liu United States 11 400 1.3× 130 0.5× 178 1.0× 199 1.8× 63 1.4× 11 628
Daizo Oka Japan 13 255 0.8× 129 0.5× 172 1.0× 129 1.2× 21 0.5× 23 567
Vilmos Adleff Hungary 15 295 0.9× 353 1.3× 171 1.0× 282 2.5× 136 3.0× 32 716
Robert Cozens Switzerland 2 330 1.1× 126 0.5× 56 0.3× 142 1.3× 20 0.4× 3 475
Silvia Bombelli Italy 12 366 1.2× 187 0.7× 287 1.6× 105 0.9× 31 0.7× 22 603
Qirong Geng China 12 172 0.5× 117 0.4× 158 0.9× 112 1.0× 33 0.7× 27 469
Akira Hirano Japan 12 220 0.7× 151 0.5× 93 0.5× 203 1.8× 97 2.2× 58 556
Hui-Lan Rao China 11 264 0.8× 142 0.5× 61 0.3× 105 0.9× 71 1.6× 13 482
Tricia Kunst United States 9 447 1.4× 106 0.4× 105 0.6× 165 1.5× 20 0.4× 12 604

Countries citing papers authored by Ella Liberzon

Since Specialization
Citations

This map shows the geographic impact of Ella Liberzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Liberzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Liberzon more than expected).

Fields of papers citing papers by Ella Liberzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella Liberzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Liberzon. The network helps show where Ella Liberzon may publish in the future.

Co-authorship network of co-authors of Ella Liberzon

This figure shows the co-authorship network connecting the top 25 collaborators of Ella Liberzon. A scholar is included among the top collaborators of Ella Liberzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Liberzon. Ella Liberzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Koduri, Vidyasagar, Samuel K. McBrayer, Ella Liberzon, et al.. (2019). Peptidic degron for IMiD-induced degradation of heterologous proteins. Proceedings of the National Academy of Sciences. 116(7). 2539–2544. 42 indexed citations
2.
Cho, Hyejin, Xinlin Du, James P. Rizzi, et al.. (2016). On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models. Nature. 539(7627). 107–111. 336 indexed citations breakdown →
3.
Yaniv, Isaac, Jerry Stein, Drorit Luria, et al.. (2007). Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation. Bone Marrow Transplantation. 39(10). 589–594. 5 indexed citations
4.
Schmilovitz‐Weiss, Hemda, Salomon M. Stemmer, Ella Liberzon, et al.. (2006). Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: A prospective pilot study. Cancer Detection and Prevention. 30(2). 204–209. 7 indexed citations
5.
Yaniv, Isaac, Ian J. Cohen, Jerry Stein, et al.. (2004). Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse. Pediatric Blood & Cancer. 42(5). 404–409. 21 indexed citations
6.
Avigad, Smadar, Ian J. Cohen, Ella Liberzon, et al.. (2004). The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer. 100(5). 1053–1058. 63 indexed citations
7.
Liberzon, Ella, Smadar Avigad, Isaac Yaniv, et al.. (2004). Molecular variants of the ATM gene in Hodgkin's disease in children. British Journal of Cancer. 90(2). 522–525. 15 indexed citations
8.
Liberzon, Ella, Smadar Avigad, Batia Stark, et al.. (2003). Germ‐line ATM gene alterations are associated with susceptibility to sporadic T‐cell acute lymphoblastic leukemia in children. Genes Chromosomes and Cancer. 39(2). 161–166. 32 indexed citations
9.
Liberzon, Ella. (2003). ATM gene mutations are not involved in medulloblastoma in children. Cancer Genetics and Cytogenetics. 146(2). 167–169. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026